Users Online: 1055
Home Print this page Email this page
Home About us Editorial board Search Browse articles Submit article Ahead of Print Instructions Subscribe Contacts Special issues Login 

    Article Cited by others

REVIEW ARTICLE

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers

Sanaei Masumeh, Kavoosi Fraidoon

Year : 2019| Volume: 8| Issue : 1 | Page no: 63-63

   This article has been cited by
 
1 The role of viruses in cancer development versus cancer therapy: An oncological perspective
Hossein Javid, Alireza Sharbaf Mashhad, Shaghayegh Yazdani, Mahsa Akbari Oryani, Sanaz Akbari, Nastaran Rezagholinejad, Mahboubeh Tajaldini, Mehdi Karimi-Shahri
Cancer Medicine. 2023;
[Pubmed]  [Google Scholar] [DOI]
2 Epigenetics and immune cells in medulloblastoma
Francesca Gorini, Marco Miceli, Pasqualino de Antonellis, Stefano Amente, Massimo Zollo, Veronica Ferrucci
Frontiers in Genetics. 2023; 14
[Pubmed]  [Google Scholar] [DOI]
3 The First-In-Class Anti-AXL×CD3e Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas
Nicoletta Polerà, Antonia Mancuso, Caterina Riillo, Daniele Caracciolo, Stefania Signorelli, Katia Grillone, Serena Ascrizzi, Craig A. Hokanson, Francesco Conforti, Nicoletta Staropoli, Luigia Gervasi, Maria Teresa Di Martino, Mariamena Arbitrio, Giuseppe Nisticò, Roberto Crea, Pierosandro Tagliaferri, Giada Juli, Pierfrancesco Tassone
Cancers. 2023; 15(6): 1647
[Pubmed]  [Google Scholar] [DOI]
4 Anticancer effects of the HDAC inhibitor, 3ß,6ß-dihydroxyurs-12-en-27-oic acid, in MCF-7 breast cancer cells via the inhibition of Akt/mTOR pathways
Jong Lim, So Kyung, Yukyoung Jeon, In Kim, Jong Kwak, Hyung Kim
Oncology Reports. 2023; 49(2)
[Pubmed]  [Google Scholar] [DOI]
5 The Role of HDACs in the Response of Cancer Cells to Cellular Stress and the Potential for Therapeutic Intervention
Rahma K. Alseksek, Wafaa S. Ramadan, Ekram Saleh, Raafat El-Awady
International Journal of Molecular Sciences. 2022; 23(15): 8141
[Pubmed]  [Google Scholar] [DOI]
6 Recent Advances in the Management of Relapsed and Refractory Peripheral T-Cell Lymphomas
Zachary Braunstein, Miguel Ruiz, Walter Hanel, Polina Shindiapina, John C. Reneau, Jonathan E. Brammer
Journal of Personalized Medicine. 2022; 12(6): 964
[Pubmed]  [Google Scholar] [DOI]
7 Clinical Implications of Necroptosis Genes Expression for Cancer Immunity and Prognosis: A Pan-Cancer Analysis
Xin-yu Li, Li-xin Su, Wen-Xue Chen, Hui Liu, Lu-yu Zhang, Yu-Chen Shen, Jian-Xiong You, Jing-Bing Wang, Liming Zhang, Deming Wang, Ming-Zhe Wen, Zhenfeng Wang, Yu-hao Shao, De-Hu Chen, Xi-tao Yang
Frontiers in Immunology. 2022; 13
[Pubmed]  [Google Scholar] [DOI]
8 Potential of histone deacetylase inhibitors in the control and regulation of prostate, breast and ovarian cancer
Siddhartha Das Pramanik, Amit Kumar Halder, Ushmita Mukherjee, Dharmendra Kumar, Yadu Nandan Dey, Mogana R
Frontiers in Chemistry. 2022; 10
[Pubmed]  [Google Scholar] [DOI]
9 DNTTIP1 is a Prognostic Biomarker Correlated With Immune Infiltrates in Hepatocellular Carcinoma: A Study Based on The Cancer Genome Atlas Data
Changyu Zhu, Rongsheng Tong, Xiaolei Jiang, Hua Xiao, Jianmei Guan, Jianchen Shu
Frontiers in Genetics. 2022; 12
[Pubmed]  [Google Scholar] [DOI]
10 Potential of histone deacetylase inhibitors for the therapy of ovarian cancer
Fengyi Guo, Hongjing Wang
Frontiers in Oncology. 2022; 12
[Pubmed]  [Google Scholar] [DOI]
11 Review: Neurological Complications From Therapies for Pediatric Brain Tumors
Thien Nguyen, Sabine Mueller, Fatema Malbari
Frontiers in Oncology. 2022; 12
[Pubmed]  [Google Scholar] [DOI]
12 HDAC8 suppresses the epithelial phenotype and promotes EMT in chemotherapy-treated basal-like breast cancer
Garyfallia Pantelaiou-Prokaki, Iga Mieczkowska, Geske E. Schmidt, Sonja Fritzsche, Evangelos Prokakis, Julia Gallwas, Florian Wegwitz
Clinical Epigenetics. 2022; 14(1)
[Pubmed]  [Google Scholar] [DOI]
13 Repression of the PRELP gene is relieved by histone deacetylase inhibitors through acetylation of histone H2B lysine 5 in bladder cancer
Kanto Shozu, Syuzo Kaneko, Norio Shinkai, Ai Dozen, Hirofumi Kosuge, Makoto Nakakido, Hidenori Machino, Ken Takasawa, Ken Asada, Masaaki Komatsu, Kouhei Tsumoto, Shin-Ichi Ohnuma, Ryuji Hamamoto
Clinical Epigenetics. 2022; 14(1)
[Pubmed]  [Google Scholar] [DOI]
14 Selective Inhibitors of Histone Deacetylase 10 (HDAC-10)
Eftiola Pojani, Daniela Barlocco
Current Medicinal Chemistry. 2022; 29(13): 2306
[Pubmed]  [Google Scholar] [DOI]
15 Histone deacetylase 4 and 5 translocation elicited by microsecond pulsed electric field exposure is mediated by kinase activity
Zahra Safaei, Gary L. Thompson
Frontiers in Bioengineering and Biotechnology. 2022; 10
[Pubmed]  [Google Scholar] [DOI]
16 Synthesis and Anticancer Potential of New Hydroxamic Acid Derivatives as Chemotherapeutic Agents
Isil Nihan Korkmaz, Hasan Özdemir
Applied Biochemistry and Biotechnology. 2022;
[Pubmed]  [Google Scholar] [DOI]
17 Novel pyridine-containing histone deacetylase inhibitors strongly arrest proliferation, induce apoptosis and modulate miRNAs in cancer cells
Elisabetta Di Bello, Veronica Sian, Giulio Bontempi, Clemens Zwergel, Rossella Fioravanti, Beatrice Noce, Carola Castiello, Stefano Tomassi, Davide Corinti, Daniela Passeri, Roberto Pellicciari, Ciro Mercurio, Mario Varasi, Lucia Altucci, Marco Tripodi, Raffaele Strippoli, Angela Nebbioso, Sergio Valente, Antonello Mai
European Journal of Medicinal Chemistry. 2022; : 115022
[Pubmed]  [Google Scholar] [DOI]
18 KDM1A/LSD1 as a promising target in various diseases treatment by regulating autophagy network
Ting Ma, Anqi Li, Yueyang Guo, Shaotong Li, Meng Li, Siqi Feng, Hongmin Liu
Biomedicine & Pharmacotherapy. 2022; 148: 112762
[Pubmed]  [Google Scholar] [DOI]
19 Design, synthesis and biological evaluation of novel hybrids targeting mTOR and HDACs for potential treatment of hepatocellular carcinoma
Shiyang Zhai,Huimin Zhang,Rui Chen,Jiangxia Wu,Daiqiao Ai,Shunming Tao,Yike Cai,Ji-Quan Zhang,Ling Wang
European Journal of Medicinal Chemistry. 2021; : 113824
[Pubmed]  [Google Scholar] [DOI]
20 A Phase 2a cohort expansion study to assess the safety, tolerability, and preliminary efficacy of CXD101 in patients with advanced solid-organ cancer expressing HR23B or lymphoma
Stephen W. Booth,Toby A. Eyre,John Whittaker,Leticia Campo,Lai Mun Wang,Elizabeth Soilleux,Daniel Royston,Gabrielle Rees,Murali Kesavan,Catherine Hildyard,Farasat Kazmi,Nick La Thangue,David Kerr,Mark R. Middleton,Graham P. Collins
BMC Cancer. 2021; 21(1)
[Pubmed]  [Google Scholar] [DOI]
21 How can exposure to engineered nanomaterials influence our epigenetic code? A review of the mechanisms and molecular targets
Luciana Moreira,Carla Costa,Joana Pires,João Paulo Teixeira,Sónia Fraga
Mutation Research/Reviews in Mutation Research. 2021; 788: 108385
[Pubmed]  [Google Scholar] [DOI]
22 Mitochondrial Proteins in Heart Failure: The Role of Deacetylation by SIRT3
Chunfang Wang,Yating Wang,Li Shen
Pharmacological Research. 2021; : 105802
[Pubmed]  [Google Scholar] [DOI]
23 Molecular mechanisms underpinning sarcomas and implications for current and future therapy
Victoria Damerell,Michael S. Pepper,Sharon Prince
Signal Transduction and Targeted Therapy. 2021; 6(1)
[Pubmed]  [Google Scholar] [DOI]
24 Characterizing binding intensity and energetic features of histone deacetylase inhibitor pracinostat towards class I HDAC isozymes through futuristic drug designing strategy
Shabir Ahmad Ganai
In Silico Pharmacology. 2021; 9(1)
[Pubmed]  [Google Scholar] [DOI]
25 Targeting the signal pathways triggered by cyclic peptides: A potential therapeutic strategy for alleviation of cancer
Yiyuan Yang,Hui Mao,Linxi Chen,Lanfang Li
Archives of Biochemistry and Biophysics. 2021; : 108776
[Pubmed]  [Google Scholar] [DOI]
26 Epigenetic Enzymes: A Role in Aging and Prospects for Pharmacological Targeting
Elena G. Pasyukova,Alexander V. Symonenko,Olga Y. Rybina,Alexander M. Vaiserman
Ageing Research Reviews. 2021; : 101312
[Pubmed]  [Google Scholar] [DOI]
27 Regulation of SIRT2 by Wnt/ß-catenin signaling pathway in colorectal cancer cells
Chang Li,Yuning Zhou,Ji Tae Kim,Tomoko Sengoku,Michael C. Alstott,Heidi L. Weiss,Qingding Wang,B. Mark Evers
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2021; 1868(4): 118966
[Pubmed]  [Google Scholar] [DOI]
28 Histone Deacetylase Sirtuin 1 Promotes Loss of Primary Cilia in Cholangiocarcinoma
Kishor Pant,Estanislao Peixoto,Seth Richard,Aalekhya Biswas,M. Gerard O’Sullivan,Nasra Giama,Yeonjung Ha,Jun Yin,Pietro Carotenuto,Massimiliano Salati,Yanan Ren,Rendong Yang,Brunella Franco,Lewis R. Roberts,Sergio A. Gradilone
Hepatology. 2021;
[Pubmed]  [Google Scholar] [DOI]
29 Quisinostat mediated autophagy is associated with differentiation in neuroblastoma SK-N-SH cells
Vamsi Krishna Kommalapati,Dinesh Kumar,Anjana Devi Tangutur
Molecular Biology Reports. 2021;
[Pubmed]  [Google Scholar] [DOI]
30 Post-translational lysine ac(et)ylation in health, ageing and disease
Anna-Theresa Blasl,Sabrina Schulze,Chuan Qin,Leonie G. Graf,Robert Vogt,Michael Lammers
Biological Chemistry. 2021; 0(0)
[Pubmed]  [Google Scholar] [DOI]
31 Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives
Robert Jenke,Nina Reßing,Finn K. Hansen,Achim Aigner,Thomas Büch
Cancers. 2021; 13(4): 634
[Pubmed]  [Google Scholar] [DOI]
32 Oncolytic Viruses in Combination Therapeutic Approaches with Epigenetic Modulators: Past, Present, and Future Perspectives
Annalisa Chianese,Biagio Santella,Annalisa Ambrosino,Debora Stelitano,Luca Rinaldi,Massimiliano Galdiero,Carla Zannella,Gianluigi Franci
Cancers. 2021; 13(11): 2761
[Pubmed]  [Google Scholar] [DOI]
33 A Novel ZIP4-HDAC4-VEGFA Axis in High-Grade Serous Ovarian Cancer
Qipeng Fan,Lihong Li,Tian-Li Wang,Robert E. Emerson,Yan Xu
Cancers. 2021; 13(15): 3821
[Pubmed]  [Google Scholar] [DOI]
34 Roles of Histone Deacetylases in Acute Myeloid Leukemia With Fusion Proteins
Juan Zhang,Xuefeng Gao,Li Yu
Frontiers in Oncology. 2021; 11
[Pubmed]  [Google Scholar] [DOI]
35 Role of HDAC6 and Its Selective Inhibitors in Gastrointestinal Cancer
Bingyi Zhou, Deliang Liu, Yuyong Tan
Frontiers in Cell and Developmental Biology. 2021; 9
[Pubmed]  [Google Scholar] [DOI]
36 8a, a New Acridine Antiproliferative and Pro-Apoptotic Agent Targeting HDAC1/DNMT1
Qiting Zhang,Ziyan Wang,Xinyuan Chen,Haoxiang Qiu,Yifan Gu,Ning Wang,Tao Wang,Ze Wang,Huabin Ma,Yufen Zhao,Bin Zhang
International Journal of Molecular Sciences. 2021; 22(11): 5516
[Pubmed]  [Google Scholar] [DOI]
37 Las propiedades epigenéticas y anticáncer del ácido valproico
Ismael Vásquez-Moctezuma,Estefanía Fernández-Navarrete,Gabriela Rebeca Luna-Palencia
Revista Mexicana de Mastología. 2020; 10(2): 54
[Pubmed]  [Google Scholar] [DOI]
38 Role of Histone Deacetylases in Carcinogenesis: Potential Role in Cholangiocarcinoma
Kishor Pant,Estanislao Peixoto,Seth Richard,Sergio A. Gradilone
Cells. 2020; 9(3): 780
[Pubmed]  [Google Scholar] [DOI]
39 Bladder Cancer Metastasis Induced by Chronic Everolimus Application Can Be Counteracted by Sulforaphane In Vitro
Saira Justin,Jochen Rutz,Sebastian Maxeiner,Felix K.-H. Chun,Eva Juengel,Roman A. Blaheta
International Journal of Molecular Sciences. 2020; 21(15): 5582
[Pubmed]  [Google Scholar] [DOI]
40 A Toxicity Prediction Tool for Potential Agonist/Antagonist Activities in Molecular Initiating Events Based on Chemical Structures
Kota Kurosaki,Raymond Wu,Yoshihiro Uesawa
International Journal of Molecular Sciences. 2020; 21(21): 7853
[Pubmed]  [Google Scholar] [DOI]
41 Epigenetic Research in Stem Cell Bioengineering—Anti-Cancer Therapy, Regenerative and Reconstructive Medicine in Human Clinical Trials
Claudia Dompe,Krzysztof Janowicz,Greg Hutchings,Lisa Moncrieff,Maurycy Jankowski,Mariusz J. Nawrocki,Malgorzata Józkowiak,Paul Mozdziak,Jim Petitte,Jamil A. Shibli,Marta Dyszkiewicz-Konwinska,Malgorzata Bruska,Hanna Piotrowska-Kempisty,Bartosz Kempisty,Michal Nowicki
Cancers. 2020; 12(4): 1016
[Pubmed]  [Google Scholar] [DOI]
42 Recent Progress in Histone Deacetylase Inhibitors as Anticancer Agents
Loredana Cappellacci,Diego R. Perinelli,Filippo Maggi,Mario Grifantini,Riccardo Petrelli
Current Medicinal Chemistry. 2020; 27(15): 2449
[Pubmed]  [Google Scholar] [DOI]
43 Histone Deacetylase Inhibitors in Pediatric Brain Cancers: Biological Activities and Therapeutic Potential
Alexandre Perla,Lívia Fratini,Paula S. Cardoso,Carolina Nör,André T. Brunetto,Algemir L. Brunetto,Caroline Brunetto de Farias,Mariane Jaeger,Rafael Roesler
Frontiers in Cell and Developmental Biology. 2020; 8
[Pubmed]  [Google Scholar] [DOI]
44 Recent Update of HDAC Inhibitors in Lymphoma
I-Chung Chen,Bidyadhar Sethy,Jing-Ping Liou
Frontiers in Cell and Developmental Biology. 2020; 8
[Pubmed]  [Google Scholar] [DOI]
45 Construction prognosis model based on autophagy-related gene signatures in hepatocellular carcinoma
Jiangtao Wang,Yandong Miao,Juntao Ran,Yuan Yang,Quanlin Guan,Denghai Mi
Biomarkers in Medicine. 2020; 14(13): 1229
[Pubmed]  [Google Scholar] [DOI]
46 A novel HDAC inhibitor chidamide combined with imatinib synergistically targets tyrosine kinase inhibitor resistant chronic myeloid leukemia cells
Bailin He,Qiang Wang,Xiaoli Liu,Ziyuan Lu,Jiaochan Han,Chengyun Pan,Bing Z. Carter,Qifa Liu,Na Xu,Hongsheng Zhou
Biomedicine & Pharmacotherapy. 2020; 129: 110390
[Pubmed]  [Google Scholar] [DOI]
47 Molecular docking-based virtual drug screening revealing an oxofluorenyl benzamide and a bromonaphthalene sulfonamido hydroxybenzoic acid as HDAC6 inhibitors with cytotoxicity against leukemia cells
Mona Dawood,Mohamed Elbadawi,Madeleine Böckers,Gerhard Bringmann,Thomas Efferth
Biomedicine & Pharmacotherapy. 2020; 129: 110454
[Pubmed]  [Google Scholar] [DOI]
48 Class IIa HDAC inhibitor TMP195 alleviates lipopolysaccharide-induced acute kidney injury
Wei Zhang,Yinjie Guan,George Bayliss,Shougang Zhuang
American Journal of Physiology-Renal Physiology. 2020; 319(6): F1015
[Pubmed]  [Google Scholar] [DOI]
49 Genome-wide identification and transcriptional modulation of histone variants and modification related genes in the low pH-exposed marine rotifer Brachionus koreanus
Young Hwan Lee,Min-Sub Kim,Haksoo Jeong,Atsushi Hagiwara,Jae-Seong Lee
Comparative Biochemistry and Physiology Part D: Genomics and Proteomics. 2020; 36: 100748
[Pubmed]  [Google Scholar] [DOI]
50 Gelated vorinostat with inner-lysosome triggered release for tumor-targeting chemotherapy
Changyong Guo,Qirong Wang,Xingjie Zhang,Fengkun Lu,Miao Sun,Peiyu Zeng,Linhong Sun,Lan She,Bingkai Wang,Yunchang Zhang,Chen Wang,Zhiqiang Ma,Feng Yang
Colloids and Surfaces B: Biointerfaces. 2020; : 111144
[Pubmed]  [Google Scholar] [DOI]
51 The Development Process: from SAHA to Hydroxamate HDAC Inhibitors with Branched CAP Region and Linear Linker
Feifei Yang,Na Zhao,Yunjie Hu,Cheng-Shi Jiang,Hua Zhang
Chemistry & Biodiversity. 2019;
[Pubmed]  [Google Scholar] [DOI]
52 Epigenetic Control of Autophagy in Cancer Cells: A Key Process for Cancer-Related Phenotypes
Paul Peixoto,Céline Grandvallet,Jean-Paul Feugeas,Michaël Guittaut,Eric Hervouet
Cells. 2019; 8(12): 1656
[Pubmed]  [Google Scholar] [DOI]

 

Read this article